Agilent Technologies: Precise measurement of material properties


Industrial, scientific and engineering operations are critically dependent on the precise measurement of basic physical parameters. Among the best known manufacturers of many of the devices required for these purposes is headquartered in Santa Clara, California.

Agilent Technologies (NYSE: A) provides electronic measurement and bio-analytical solutions to the communications, electronics, life sciences and chemical analysis industries. Its Electronic Measurement segment offers such instruments as data generators, multimeters, and oscilloscopes. Its Bio-Analytical Measurement segment provides instruments and consumables that enable customers to quantify the biological properties of substances. Customers include Cisco Systems (NASDAQ: CSCO), Dow Chemical (NYSE: DOW), Intel (NASDAQ: INTC) and Merck (NYSE: MRK). The firm was a 1999 spin-off of Hewlett-Packard (NYSE: HPQ).

Agilent announced the acquisition of life science research and diagnostic products firm Stratagene last week and said that, as a result, it expects Q3 revenues to be in the range $1.38-$1.42 billion. Analysts had been looking for $1.38 billion. The acquisition did not affect the company's earnings outlook. The news kept Agilent shares cycling through a positive two-month trading channel. The price is currently consolidating at the base of that channel, where oversold CCI, MACD, Momentum, RSI and Stochastic technical parameters suggest the potential for a rise back toward the top. Correspondence of the stock's 30-day moving average curve to the base of the channel backs the rebound notion.

Brokers recommend the issue with two "strong buys," three "buys" and four "holds." Analysts expect a 19% growth rate through the next year. The Agilent Price to Free Cash Flow ratio (21.92), Operating Margin (11.09%), Net Profit Margin (12.48%), Return on Assets (7.82%) and Return on Investment (10.00%) compare favorably with industry averages.

Institutional investors hold about 74% of the outstanding shares. The stock is one of those used to calculate the S&P 500 Index. Over the past 52 weeks, it has traded between $26.96 and $38.97. A stop-loss of $32.70 looks good here. Note that the firm expects to report Q3 results in mid-August.

Larry Schutts is a contributing editor for Theflyonthewall.com and the Vice-President of Stockwinners.com.

Symbol Lookup
IndexesChangePrice
DJIA+49.2712,850.50
NASDAQ+16.622,920.50
S&P 500+6.201,348.84

Last updated: February 13, 2012: 11:54 AM

Hot Stocks

General Electric

19.04+0.165(+0.87)

Alcoa

10.375+0.085(+0.83)

Apple Inc

499.92+6.50(+1.32)

Google Inc 'A'

613.00+7.09(+1.17)

Bank of America

8.275+0.205(+2.54)

Wal-Mart Stores

61.97+0.07(+0.11)

Exxon Mobil Corp

84.16+0.36(+0.43)

Ford

12.555+0.115(+0.92)

Citigroup

33.42+0.495(+1.50)

IBM

192.56+0.14(+0.07)

Yahoo

16.11-0.03(-0.19)

Starbucks

49.25+0.43(+0.88)

Microsoft

30.58+0.085(+0.28)

Home Depot

45.875+0.545(+1.20)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329152058438 ms.